{"id":"W4406943114","doi":"10.1016/j.cllc.2025.01.011","title":"Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"F. Hoffmann-La Roche; Roche Canada","keywords":"Medicine; Atezolizumab; Internal medicine; Adverse effect; Clinical endpoint; Thymic carcinoma; Phases of clinical research; Carcinoma; Oncology; Toxicity; Gastroenterology; Surgery; Cancer; Clinical trial; Chemotherapy; Immunotherapy; Pembrolizumab","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002349296,0.000890407,0.001739679,0.0002878236,0.0003814519,0.000479398,0.0005767651,0.0007225017,0.001178034],"category_scores_gemma":[0.0009279386,0.0003746242,0.001116757,0.0003478797,0.000638285,0.000501104,0.0002904542,0.0009926732,0.0002482585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008190548,"about_ca_system_score_gemma":0.001526153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007644857,"about_ca_topic_score_gemma":0.0014796,"domain_scores_codex":[0.9996177,0.0001687991,0.00003144194,0.00006934113,0.00005662384,0.00005613103],"domain_scores_gemma":[0.9991042,0.0001303548,0.0002391399,0.0001040325,0.0001005403,0.0003217225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6089734,0.05621994,0.132997,0.001929978,0.005737964,0.0006376786,0.0007410398,0.003130949,0.05262869,0.0001700675,0.002577849,0.1342554],"study_design_scores_gemma":[0.3970201,0.3983358,0.1884978,0.00005378935,0.002461709,0.0008405409,0.0001585903,0.003301254,0.005822346,0.0001848472,0.00323144,0.00009181458],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983237,0.0007241038,0.0001343891,0.00006537445,0.00001641079,0.0004017092,0.0001538307,0.00001148962,0.0001689091],"genre_scores_gemma":[0.9971878,0.0005653729,0.0004541147,0.0002593794,0.00005962059,0.0005964232,0.0004814395,0.000004920744,0.0003908237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002349296,"threshold_uncertainty_score":0.01242447,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01500235137361954,"score_gpt":0.3897684187349703,"score_spread":0.3747660673613507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}